The size of a cell is determined by a combination of synthesis, self-assembly, incoming matter and the balance of mechanical forces. Such processes operate at the single-cell level, but they are deeply interconnected with cell-cycle progression, resulting in a stable average cell size at the population level. Here, we examine this phenomenon by reviewing the physics of growth processes that operate at vastly different timescales, but result in the controlled production of daughter cells that are close copies of their mothers. We first review the regulatory mechanisms of size at short timescales, focusing on the contribution of fundamental physical forces. We then discuss the multiple relevant regulation processes operating on the timescale of the cell cycle. Finally, we look at how these processes interact: one of the most important challenges to date involves bridging the gap between timescales, connecting the physics of cell growth and the biology of cell-cycle progression.
Robots from all over the world are about to go on a subterranean adventure, competing against each other in mining tunnels to determine which ones can best navigate and find objects underground and do so autonomously.
The Defense Advanced Research Projects Agency (DARPA) is hosting the Subterranean Challenge Systems Competition on Aug. 15–22 in Pittsburgh as a way to develop technology for the military and first responders to map and search subterranean areas.
Metallicus, the startup behind the peer-to-peer payments platform Metal Pay, received an undisclosed angel investment from the youngest bitcoin millionaire, Erik Finman.
In partnership with Metal Pay CEO Marshall Hayner, the two look to develop the first “all-in-one” cryptocurrency banking platform, which includes a 17 digital asset exchange, a digital bank and a payments application with social features similar to Venmo.
Founded in September, Metal Pay has processed approximately $11 million in total payments from nearly 130,000 registered users across 38 states. On a monthly basis, the company processes $1 million in crypto or fiat for around 30,000 active users, according to Hayner.
Physics World represents a key part of IOP Publishing’s mission to communicate world-class research and innovation to the widest possible audience. The website forms part of the Physics World portfolio, a collection of online, digital and print information services for the global scientific community.
Before scientists discovered the new state of matter last week, we were basically all used to just three states of matter. After all, during our daily lives we encounter some variety of solids, liquids and gases. Solids hold a definite shape without a container, liquids conform to the shape of their container, and gases not only conform to a container, but also expand to fill it.
And there’s variety amidst these three: A crystalline solid, for example, has all its atoms lined up in exactly the precise order in perfect symmetry, while a quasicrystal solid fills all its space without the tightly regulated structure. Liquid crystals, which make up the visual components of most electronic displays, have elements of both liquids and crystal structures, as anyone who has ever pushed the screen of their calculator can confirm.
Under standard conditions on Earth, solids, liquids and gasses are the vast majority of what a person will experience in life. But that doesn’t mean there’s not a whole lot more beneath the surface.
The evolving gene-editing technology CRISPR-Cas9 is useful for changing one gene, or maybe a few genes at a time. A team at ETH Zurich has tweaked the technology so they can change 25 different gene sites at once. Instead of using the Cas9 enzyme to do the DNA cutting, though, they used Cas12a. That allowed them to create a long “address list” of gene sites to target, they explained in the journal Nature Methods. They created a DNA molecule called a plasmid to store the list, inserted it in human cells and were able to modify several genes, they reported. (Release)
Chemotherapy and radiation suppress blood stem cells, often for several weeks or even months after cancer treatments are complete. This leaves patients vulnerable to infections and other health problems. Scientists at the University of California, Los Angeles have created a new drug that targets the protein tyrosine phosphatase-sigma (PTP-sigma), which is prevalent on blood stem cells. They showed that blocking the protein in rodent models with the drug, called DJ009, helped blood cells recover more quickly after they were damaged by radiation. They published their findings in the journal Nature Communications. (Release)
Supplementing psychotherapy with small doses of MDMA could be an effective strategy to prevent relapses of alcohol addiction in patients, an ongoing small clinical trial suggests. The research is yet another example of how scientists and doctors are finding or rediscovering therapeutic uses for recreational and illicit drugs.
MDMA-assisted therapy is actually an old idea, which enjoyed some popularity in the 1970s and 1980s. Though the exact mechanisms are unclear, the synthetic drug’s euphoric effects are thought to amplify the positive patterns of thinking taught by therapy, as well as make people feel less anxious during sessions. Of course, these same mood-boosting attributes made MDMA a popular recreational drug. This popularity led the U.S. government to ban MDMA in 1985, by classifying it as a Schedule 1 drug with no accepted medical use.
New Treatment for Schizophrenia
Posted in neuroscience
Scientists discovered the Origin of Schizophrenia and managed to treat it!
Ever been frustrated waiting for your YouTube video to stream quickly? A team of experts from MIT has created a system that allows multiple Wi-Fi users to stream and buffer high-quality videos.
Smart contact lenses will allow you to zoom in and record what you see!